secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pacira BioSciences, Inc. (PCRX)
CIK:        0001396814
Form:       8-K
Filed at:   2026-06-30T11:31:57+00:00
Accession:  0001628280-26-046136
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pacira divests iovera business to Zimmer Biomet for up to $140M
---------------------------------------------------------------

- Upfront payment of $70M; potential milestone payments up to $70M through 2031.
- 66 employees (~8% of workforce) expected to be hired by Zimmer Biomet at close.
- Pacira to use net proceeds to pay down senior secured revolving credit facility.
- Parties to collaborate on advancing spasticity program; incremental compensation possible.
- Transaction expected to close in Q3 2026, subject to customary conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1396814/000162828026046136/0001628280-26-046136-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1396814/000162828026046136/pcrx-20260628.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-046136

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer